Evidence map›Paper›PMID 38453813›Full record

ArticleEJNMMI research2024

Evaluation of the theranostic potential of [

Catarina I G Pinto, André D M Branco, Sara Bucar, Alexandra Fonseca, Antero J Abrunhosa, Cláudia L da Silva, Joana F Guerreiro, Filipa Mendes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. In Vitro Radiobiological Evaluation of [Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Catarina I G PintoC2TN - Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
André D M BrancoDepartment of Bioengineering, iBB - Institute for Bioengineering and Biosciences, Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Sara BucarDepartment of Bioengineering, iBB - Institute for Bioengineering and Biosciences, Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Alexandra FonsecaCIBIT/ICNAS Instituto de Ciências Nucleares Aplicadas à Saúde, Universidade de Coimbra, Coimbra, Portugal.
Antero J AbrunhosaCIBIT/ICNAS Instituto de Ciências Nucleares Aplicadas à Saúde, Universidade de Coimbra, Coimbra, Portugal.
Cláudia L da SilvaDepartment of Bioengineering, iBB - Institute for Bioengineering and Biosciences, Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Joana F GuerreiroC2TN - Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Filipa MendesC2TN - Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. fmendes@ctn.tecnico.ulisboa.pt.ORCID http://orcid.org/0000-0003-0646-1687
University of Lisbon · PTInstituto Superior de Gestão · PTUniversity of Coimbra · PTInstituto de Engenharia de Sistemas e Computadores Investigação e Desenvolvimento · PT

Funding

Fundação para a Ciência e a Tecnologia (FCT), UID/Multi/04349/2019Fundação para a Ciência e Tecnologia UIDB/04565/2020Fundação para a Ciência e Tecnologia (FCT) Fellowship 2020.07119.BDLisboa 2022 Project N. 007317
6 · The paper itself

Abstract

backgroundGlioblastoma is an extremely aggressive malignant tumor with a very poor prognosis. Due to the increased proliferation rate of glioblastoma, there is the development of hypoxic regions, characterized by an increased concentration of copper (Cu). Considering this,

resultsResults revealed that [

conclusionsOverall, our results further support [

Indexed as

Copper-64 chlorideGlioblastomaRadiobiologySpheroidsTheranostics

Identifiers

PMID38453813
PMCPMC10920519
OpenAlexW4392546634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.